Approval · Notice of Compliance 15610 · 2014
PRECEDEX: Notice of Compliance 15610
Issued May 20, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15610
- Date
- May 20, 2014
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Information on safety and clinical pharmacology for children
- Therapeutic class
- Alpha2-adrenergic agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRECEDEX | Not yet assigned | — |
Medicinal ingredients
- DEXMEDETOMIDINE HYDROCHLORIDE 100 MCG per ML